🇺🇸 FDA
Patent

US 10130594

Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

granted A61KA61K31/137A61K45/06

Quick answer

US patent 10130594 (Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/137, A61K45/06, A61P, A61P35/00